Immunotherapy Before and After Lung Cancer Surgery Reduces Death Risk, Disease Recurrence
Johns Hopkins MedicinePeople with operable non-small cell lung cancers may fare better over the next few years by receiving immunotherapy treatments before and after surgery instead of only before surgery, according to a new analysis by Johns Hopkins Kimmel Cancer Center investigators.